{"transactions":[{"id":2545293,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":134735,"kind":"person","name":"Norton Evan","position":1,"cik":"0001856303","reported_name":"Norton Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T22:17:33.000Z","date":"2021-04-21","kind":"grant","acquired":true,"shares":21698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021."}],"balance_after":21698,"derivative":{"exercise_price":17,"expiration_date":"2031-04-20","underlying":"Common Stock","underlying_shares":21698},"source":{"system":"sec-edgar","filing":"0001209191-21-060106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000120919121060106/doc4.xml","form_type":"4"}},{"id":2739395,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":134735,"kind":"person","name":"Norton Evan","position":1,"cik":"0001856303","reported_name":"Norton Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B' Preferred Stock","published_at":"2021-04-26T21:18:53.000Z","date":"2021-04-26","kind":"exercise","acquired":false,"shares":3454422,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by Accelmed Partners II LP.  Accelmed Partners II, LLC (\"Accelmed LLC\") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3454422},"source":{"system":"sec-edgar","filing":"0001209191-21-028329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000120919121028329/doc4.xml","form_type":"4"}},{"id":2739394,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":134735,"kind":"person","name":"Norton Evan","position":1,"cik":"0001856303","reported_name":"Norton Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-26T21:18:53.000Z","date":"2021-04-26","kind":"exercise","acquired":true,"shares":3454422,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by Accelmed Partners II LP.  Accelmed Partners II, LLC (\"Accelmed LLC\") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC."}],"balance_after":4042657,"source":{"system":"sec-edgar","filing":"0001209191-21-028329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000120919121028329/doc4.xml","form_type":"4"}},{"id":2740608,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":134735,"kind":"person","name":"Norton Evan","position":1,"cik":"0001856303","reported_name":"Norton Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-23T23:26:10.000Z","date":"2021-04-21","kind":"purchase","acquired":true,"shares":588235,"price":17,"value":9999995.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares purchased from the underwriters in the Companys initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Accelmed Partners II LP.  Accelmed Partners II, LLC (\"Accelmed LLC\") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC. The address of each of Accelmed LLC, Accelmed Partners II GP, LP, Accelmed Partners II LP and Mr. Norton is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands."}],"balance_after":588235,"source":{"system":"sec-edgar","filing":"0001209191-21-028188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000120919121028188/doc4.xml","form_type":"4"}}]}